Sign in
Recurrent inactivating RASA2 mutations in melanoma
Journal article   an open version is available  Peer reviewed

Recurrent inactivating RASA2 mutations in melanoma

Rand Arafeh, Nouar Qutob, Rafi Emmanuel, Alona Keren-Paz, Jason Madore, Abdel Elkahloun, James S. Wilmott, Jared J. Gartner, Antonella Di Pizio, Sabina Winograd-Katz, …
Nature Genetics, Vol.47(12), pp.1408-1410
Dec/2015
url
http://europepmc.org/articles/pmc4954601View
Acceptedhttps://www.ncbi.nlm.nih.gov/pmc/about/copyright/Other Open Access
url
https://doi.org/10.1038/ng.3427View
Published (Version of record) Restricted

Abstract

Analysis of 501 melanoma exomes identified RASA2, encoding a RasGAP, as a tumor-suppressor gene mutated in 5% of melanomas. Recurrent loss-of-function mutations in RASA2 were found to increase RAS activation, melanoma cell growth and migration. RASA2 expression was lost in >= 30% of human melanomas and was associated with reduced patient survival. These findings identify RASA2 inactivation as a melanoma driver and highlight the importance of RasGAPs in cancer.

Details

Metrics

10 Record Views